Furthermore, the interactions between cancer cells and the surrounding microenvironment [32, 33], as well as their secreted cytokines and growth factors (for example, IL-6 and stromal cell-derived factor 1), and altering the ECM [34] may also play key roles to development of docetaxel resistance. This evidence concerns the gene IL6 and cancer.